ARCHIVES

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

House Approves Additional Funds For NIH and FDA.

June 20, 2008

NCI program announcement available, contract awards listed.

November 14, 2003

In Brief: Jennifer Pietenpol Named to IOM Cancer Policy Board

July 18, 2014

Study Finds Green Tea No Help In Advanced Prostate Cancer

March 28, 2003

FDA Expands Gleevec Indication For Children with Ph+ ALL

January 25, 2013